Literature DB >> 6287683

Circulating factor from a kala-azar patient suppresses in vitro antileishmanial T cell proliferation.

D J Wyler.   

Abstract

In vitro lymphocyte blastogenesis stimulated by phytohaemagglutinin (PHA), streptococcal antigens (SKSD) and leishmanial antigens were used to assess T cell responsiveness in one patient with kala-azar before and after therapy. During the illness, responses to PHA and SKSD but not to leishmanial antigens could be detected. After treatment lymphocytes responded to all three stimuli when cells were cultured in convalescent plasma, but failed to respond to leishmanial antigens when cultured in plasma obtained before treatment. These observations suggest the presence of a circulating inhibitor of anti-leishmanial T cell responsiveness in kala-azar, and warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287683     DOI: 10.1016/0035-9203(82)90174-2

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  Suppression of T-lymphocyte responses to Entamoeba histolytica antigen by immune sera.

Authors:  R A Salata; A Martinez-Palomo; L Canales; H W Murray; N Trevino; J I Ravdin
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

2.  Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis.

Authors:  B Galvão-Castro; J A Sá Ferreira; K F Marzochi; M C Marzochi; S G Coutinho; P H Lambert
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

3.  Serosuppression in experimental filariasis.

Authors:  P J Lammie; S P Katz; W H Anderson
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

4.  Interleukin 10 production correlates with pathology in human Leishmania donovani infections.

Authors:  H W Ghalib; M R Piuvezam; Y A Skeiky; M Siddig; F A Hashim; A M el-Hassan; D M Russo; S G Reed
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis.

Authors:  J P Haldar; S Ghose; K C Saha; A C Ghose
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

6.  Evaluation of serum levels of soluble CD4, CD8 and beta 2-microglobulin in visceral human leishmaniasis.

Authors:  G Vitale; C Mocciaro; R Malta; G Gambino; A Spinelli; C Giordano; G Stassi; F Arcoleo; S Milano; E Cillari
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

7.  The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients.

Authors:  G Vitale; G Reina; S Mansueto; R Malta; G Gambino; C Mocciaro; R D'Agostino; M Dieli; E Cillari
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

8.  Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters.

Authors:  C Gifawesen; J P Farrell
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.